COMMUNIQUÉS West-GlobeNewswire

-
Tapping Into the Fastest Growing Segment in the Beverage Industry, Diamond CBD Announces the Arrival of New Brain Chill Slushy Machines
04/02/2019 -
Pugliese Ciaccio First Hospital in Italy to Adopt Milestone Scientific’s CompuFlo® Instrument
04/02/2019 -
Data Published in the Journal of Parkinson’s Disease Demonstrate Real-World Clinical Benefit of Global Kinetics’ Personal KinetiGraph® in Optimizing Parkinson’s Disease Therapy
04/02/2019 -
BLVD Centers Changing Name to “Ventura Cannabis and Wellness Corp.” and Undertaking Share Consolidation
04/02/2019 -
Cannabis Beverages: 4 Stocks That Could Dominate the Space
04/02/2019 -
SI-BONE, Inc. Announces Additional Exclusive Coverage Policies for iFuse
04/02/2019 -
Golden Leaf Holdings Appoints Karyn O. Barsa as Chief Financial Officer
04/02/2019 -
Ultragenyx Appoints Shehnaaz Suliman, M.D., to Board of Directors
04/02/2019 -
Hemostemix Announces Submission of Orphan Drug Designation Application to the FDA
04/02/2019 -
Eastern Missouri Court Rules in Favor of Kane Biotech in Lawsuit Against Nestle Purina
04/02/2019 -
Advantis Corp. Acquiring New Canning Machine, Finalizing Sublingual Strip Agreement
04/02/2019 -
Aura Health Announces $5 Million Brokered Subscription Receipt Financing
04/02/2019 -
BrainStorm to Present at 2019 BIO CEO & Investor Conference and Extracellular Vesicles in Diagnostics & Therapeutics Symposium
04/02/2019 -
Avalon GloboCare CEO David Jin, M.D., Ph.D. to Co-Chair the “Status of Cellular Therapy in the Asia Pacific Rim” Session at the Annual Meetings of the Transplantation and Cellular Therapy (TCT) -- ASBMT and CIBMTR Tandem Meeting 2019
04/02/2019 -
BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA®
04/02/2019 -
Heritage Valley Health System expands Allscripts partnership to improve physician satisfaction and drive consumer and population health initiatives
04/02/2019 -
Melinta Therapeutics Provides Corporate Updates
04/02/2019 -
AIT Receives $3.15 Million Milestone Payment from Commercialization Partner Circassia Pharmaceuticals
04/02/2019 -
Mayo Clinic to Conduct US “VIVA” Trial for Veinplicity
04/02/2019
Pages